HOME ABOUT INVESTOR NEWS CALENDAR CONTACT All News Press Releases News 2021-06-16 16:34 Extra bolagsstämma och slutredovisning i Serendipity Ixora 2021 Extra bolagsstämma i Serendipity Ixora AB (Slutredovisning) Datum: 30 juni 2021 Alla dokument: Kallelse till extra bolagsstämma 30 juni […] News 2021-03-09 08:48 Extra bolagsstämma i Serendipity Ixora 2021 Extra bolagsstämma i Serendipity Ixora AB Datum: 31 mars 2021 Alla dokument: Kallelse till extra bolagsstämma 31 mars 2021 Poströsta […] News 2020-06-02 12:58 Årsstämma Serendipity Ixora 2020 Årsstämma i Serendipity Ixora AB Datum: Fredag den 30 juni 2020 Alla dokument: Kallelse till Årsstämman 2020 Årsredovisning 2019 Poströsta […] News 2019-04-02 12:17 Serendipity Ixora distributes most of its assets to shareholders In accordance with the decision taken on the extra ordinary general meeting January 14th 2019 to voluntarily liquidate […] News 2018-11-21 13:02 Distribution of assets of Serendipity Ixora to its shareholders Distribution of assets of Serendipity Ixora to its shareholders Serendipity Ixora has previously informed the shareholders that the company […] News 2018-11-21 13:01 Epiris acquires Diamorph for SEK 1.5 billion Epiris acquires all shares in Diamorph for a total of approximately SEK 1.5 billion Serendipity Ixora has entered […] News 2018-08-17 11:51 Episurf Medical will exhibit at the 2018 SOF Congress, held in Karlstad, Sweden, on August 27-31 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 2018 SOF Congress (Swedish Orthopaedic Association), held in Karlstad, […] News 2018-08-15 07:55 New Australian patent approval for Episurf Medical The Australian patent office IP Australia has announced that Episurf Medical (NASDAQ: EPIS B) has obtained another granted […] News 2018-08-14 09:13 Episurf Medical to present at Börsveckans Småbolagsdag, held in Stockholm, September 5 Episurf Medical will present at Börsveckans Småbolagsdag, a small-cap investor conference, held in Stockholm on September 5 (Operaterassen, […] News 2018-08-03 06:48 New Australian patent approval for Episurf Medical The Australian patent office IP Australia has announced that Episurf Medical (NASDAQ: EPIS B) has obtained another granted […] News 2018-08-03 06:48 New US patent approval for Episurf Medical Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark […] News 2018-07-30 13:58 American outerwear brand GoLite choses OrganoTex as its water repellent treatment American outerwear brand GoLite choses OrganoTex as its water repellent treatment (DWR). Products with OrganoTex will be launched […] News 2018-07-30 09:18 Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant Episurf Medical (NASDAQ: EPIS B) today announces that the company has received initial feedback from the US Food […] News 2018-07-20 08:30 Episurf Medical: INTERIM REPORT 1 APRIL– 30 JUNE 2018 “Our business in Europe is growing, driven by Germany which now starts to show signs of real commercial […] News 2018-07-16 12:30 Xbrane invites to a webinar about the recently entered co-development agreement with STADA Xbrane Biopharma AB (“Xbrane”) invites investors, analyst and media to a webinar where the recently disclosed co-development agreement […] News 2018-07-16 08:00 IRRAS Receives FDA Clearance for IRRAflow® in the US IRRAflow is a transformative medical device that combines controlled irrigation with ongoing fluid drainage for the treatment of […] News 2018-07-12 17:00 Xbrane and STADA enter into a co-development agreement for Xlucane Xbrane Biopharma AB (“Xbrane”) and STADA Arzneimittel AG (“STADA”) have entered into a co-development agreement for Xlucane, a […] News 2018-07-06 13:30 New Japanese patent approval for Episurf Medical The Japanese patent office JPO has announced its intention to grant another Japanese patent for Episurf Medical (NASDAQ: […] News 2018-06-29 09:02 Change in number of shares and votes in Episurf Medical On the behalf of shareholders in Episurf Medical AB (NASDAQ: EPIS B), conversions of class A shares to […] News 2018-06-29 07:27 OrganoClick and BAUX signs collaboration agreement OrganoClick has today entered into a collaboration agreement with fast growing BAUX to develop new interior design products […] News 2018-06-28 08:36 Episurf Medical submits IDE application to the US FDA for the Episealer® knee implant Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached an important milestone on its strategy […] News 2018-06-27 07:59 Houdini new brand partner for OrganoTex® Textile waterproofing The Swedish outdoor company Houdini has had a fast growt during several years, with their in-house designed outdoor […] News 2018-06-26 18:00 Further clinical results from the use of Episealer® to be presented at the annual meeting of the German Knee Society Episurf Medical (NASDAQ: EPIS B) today announces that the scientific abstract “Clinical 2 years results after implantation of patient-specific […] News 2018-06-25 07:07 Episealer® clinical results accepted for presentation at the German Knee Society Congress Episurf Medical (NASDAQ: EPIS B) today announces further progress on its important strategy of generating clinical results from […] News 2018-06-18 14:14 ORGANOTEX® winner of Scandinavian Outdoor Awards Sustainability price Every year, Scandinavian Outdoor Group hands out Scandinavian Outdoor Awards, at the international trade fair Outdoor in Germany. […] News 2018-06-14 10:22 Filippa K launches textile impregnation in collaboration with OrganoClick Filippa K offers since several years garment care products for sale in their stores and webshop. From September, […] News 2018-06-11 07:43 Episealer® presentation at the ISKSAA Global Summit in Leeds, UK on June 21, 2018 Episurf Medical (NASDAQ: EPIS B) today announces that Professor Leif Ryd will speak at the ISKSAA Global Summit […] News 2018-06-08 13:34 Resolutions from the 2018 Annual General Meeting in Diamorph AB (publ) The Annual General Meeting approved the Group’s and the Company’s income statements and balance sheets for the fiscal […] 2018-06-05 19:30 Trading in warrants series TO4B 2018/2023 commences on 7 June 2018 On Thursday, 7 June 2018, Episurf Medical AB (“Episurf”) warrants of series TO4B 2018/2023 will be listed for […] 2018-06-04 12:11 Bulletin from Annual General Meeting in IRRAS AB on June 1, 2018 The Annual General Meeting (the ”AGM”) on June 1, 2018 decided to adopt the balance sheet, income statement, […] COMPANY INFO INFO@SERENDIPITY.SE STUREPLAN 15 SE-111 45 STOCKHOLM SWEDEN PORTFOLIO COMPANIES DIAMORPH EPISURF MEDICAL ORGANOCLICK IRRAS PREMUNE SWECURE XBRANE BIOPHARMA VOFF SCIENCE Copyright All Rights Reserved © 2015